Total Funding
63
41
Total FundingVenture - Series Unknown raised
Growth Score 63 in past quarter
-7 pts
Heat Score 41 in past quarter
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
128294
TransCure bioServices provides predictive, preclinical R&D expertise via its services to the pharmaceutical and biotechnology industry.
Acquired by 

Taconic Biosciences
- Sebastien Tabruyn: PresidentPast Role: TransCure bioServices, Chief Executive Officer
About the Company
TransCure bioServices has developped unique Research & Development (R&D) platforms, called the Humanized Immune System (HIS) and Human Immunodeficiency Virus (HIV) mouse models. They provide access to these platforms as a fee-for-service for the pharmaceutical companies, biotechs as well as academic laboratories which profile new drugs
targeting immuno-related diseases and novel anti-HIV/AIDS therapies.